W M Kast - JoVE Visualize

Showing results (61-70 of 128) with videos related to

Pageof 13

Sort By:

Behring Institute Mitteilungen|July 1, 1994

Tumor rejection antigens and tumor specific cytotoxic T lymphocytesR E Toes, R Offringa, M C Feltkamp, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1990

Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cellsW M Kast, J A Bluestone, M H Heemskerk, et al.

International Immunology|September 28, 2007

Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLsRaymond M Wong, Ron R Scotland, Roy L Lau, et al.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|August 5, 1998

The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humansC M Matker, P Rizzo, H I Pass, et al.

AIDS (London, England)|February 1, 1995

Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptaseS H van der Burg, M R Klein, C J van de Velde, et al.

Virology|October 30, 1998

L1-specific protection from tumor challenge elicited by HPV16 virus-like particlesM L De Bruijn, H L Greenstone, H Vermeulen, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995

Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequencesA Neisig, J Roelse, A J Sijts, et al.

European Journal of Immunology|December 1, 1988

Mechanism of skin allograft enhancement across an H-2 class I mutant difference. Evidence for involvement of veto cellsW M Kast, E Van Twuyver, R J Mooijaart, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptideW M Kast, L Roux, J Curren, et al.

The EMBO Journal|August 1, 1990

Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cellsS J van den Heuvel, T van Laar, W M Kast, et al.

Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:

Pageof 13

Behring Institute Mitteilungen|July 1, 1994

Tumor rejection antigens and tumor specific cytotoxic T lymphocytesR E Toes, R Offringa, M C Feltkamp, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1990

Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cellsW M Kast, J A Bluestone, M H Heemskerk, et al.

International Immunology|September 28, 2007

Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLsRaymond M Wong, Ron R Scotland, Roy L Lau, et al.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|August 5, 1998

The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humansC M Matker, P Rizzo, H I Pass, et al.

AIDS (London, England)|February 1, 1995

Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptaseS H van der Burg, M R Klein, C J van de Velde, et al.

Virology|October 30, 1998

L1-specific protection from tumor challenge elicited by HPV16 virus-like particlesM L De Bruijn, H L Greenstone, H Vermeulen, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995

Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequencesA Neisig, J Roelse, A J Sijts, et al.

European Journal of Immunology|December 1, 1988

Mechanism of skin allograft enhancement across an H-2 class I mutant difference. Evidence for involvement of veto cellsW M Kast, E Van Twuyver, R J Mooijaart, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptideW M Kast, L Roux, J Curren, et al.

The EMBO Journal|August 1, 1990

Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cellsS J van den Heuvel, T van Laar, W M Kast, et al.

Pageof 13